aXichem Overview
- Founded
- 1999

- Status
- Public
- Employees
- 6

- Stock Symbol
- AXIC A

- Share Price
- $1.53
- (As of Tuesday Closing)
aXichem General Information
Description
aXichem AB develops and delivers nature-identical ingredients of the highest purity. The company offers axiphen-feed used in the breeding of chicken and pigs, Bio-repellents used to repel unwanted biological organisms from installations or areas and aXivite an alternative to capsaicin.
Contact Information
- Södergatan 26
- 211 34 Malmö
- Sweden
aXichem Stock Performance
(As of Tuesday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$1.53 | $1.51 | $1.31 - $3.95 | $25M | 16.5M | 11.5K | -$0.10 |
aXichem Financials Summary
In Thousands, USD |
TTM 30-Sep-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 |
---|---|---|---|---|
EV | 49,154 | 93,251 | 140,168 | 121,519 |
Revenue | 408 | 133 | 36 | 40 |
EBITDA | (1,309) | (1,223) | (1,116) | (965) |
Net Income | (1,590) | (1,466) | (1,326) | (1,141) |
Total Assets | 7,315 | 6,796 | 7,385 | 4,276 |
Total Debt | 0 | 0 | 0 | 827 |
aXichem Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore aXichem‘s full profile, request access.
Request a free trialaXichem Patents
aXichem Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2018351640-A1 | Synthetic capsaicin analogues as bioenhancers | Pending | 20-Oct-2017 | 000000000 | |
US-20200253902-A1 | Synthetic capsaicin analogues as bioenhancers | Pending | 20-Oct-2017 | 0000000000 | |
JP-2021500402-A | Synthetic capsaicin analog as a bioenhancer | Pending | 20-Oct-2017 | 0000000000 | |
EP-3697402-A1 | Synthetic capsaicin analogues as bioenhancers | Pending | 20-Oct-2017 | 000000000 | |
JP-2018530351-A | Avian and in particular poultry feeds containing synthetic capsaicinoid derivatives, and such feeds for the prophylactic use or treatment of salmonella infections | Granted | 09-Oct-2015 | A23K20/111 |
aXichem Executive Team (3)
aXichem Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
0000000 0000000 | aXichem | Chief Executive Officer & Board Member | 000 0000 |
aXichem Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial